G. C. Misty

Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval

J. Wagner, T. Marbury, K. Gottesdiener, 2008, Journal of clinical pharmacology.